Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2024, Vol. 147, No. 1
Chronic Lymphocytic Leukaemia (CLL) in the Era of New Targeted Therapies

Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 1–3. https://doi.org/10.1159/000536179

Editorial

Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 5–7. https://doi.org/10.1159/000533232

Review

Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 8–21. https://doi.org/10.1159/000533610
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 22–32. https://doi.org/10.1159/000534846
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 33–46. https://doi.org/10.1159/000533704
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 47–59. https://doi.org/10.1159/000534730
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 60–72. https://doi.org/10.1159/000534540
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 73–83. https://doi.org/10.1159/000533664
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 84–98. https://doi.org/10.1159/000533234
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (1): 99–112. https://doi.org/10.1159/000534341
Close Modal

or Create an Account

Close Modal
Close Modal